The aim of this study was to test the protective effect of an Na+/H+ exchange (NHE) inhibitor,
SM-20550, on
ischemia/reperfusion-induced endothelial dysfunction. Isolated rat hearts were subjected to 30 min of global
ischemia followed by 20 min of reperfusion and their responses to the endothelial-dependent
vasodilator,
acetylcholine, and the endothelial-independent
vasodilator,
nitroglycerin, before and after
ischemia were examined.
Acetylcholine-induced relaxation was impaired after
ischemia/reperfusion while
nitroglycerin induced relaxation was not. Administration of 1-10 nmol/l
SM-20550 [N-(aminoiminomethyl)-1,4-dimethyl-1H-
indole-2-carboxamide
methanesulfonic acid] before and after
ischemia prevented impairment of
acetylcholine-induced relaxation. To further understand the mechanism of
SM-20550 in protecting endothelial function, we measured the inhibitory activity of
SM-20550 on NHE in cultured endothelial cells.
SM-20550 (1-100 nmol/l) inhibited recovery from
acidosis induced by an NH4Cl prepulse in a concentration-dependent manner.
Oxygen radicals from endothelial cells and leukocytes are one of the major sources of endothelial cell injury during
ischemia and reperfusion. Consequently, we tested the effect of
SM-20550 on H2O2-induced endothelial cell injury.
SM-20550 (100-1,000 nmol/l) prevented H2O2-induced cell injury measured by
lactate dehydrogenase assay. In conclusion,
SM-20550 inhibited NHE in endothelial cells, protected
ischemia/reperfusion-induced endothelial dysfunction and prevented H2O2-induced endothelial cell injury at higher concentrations.